An open-label, randomized controlled trial of sulfamethoxazole-trimethoprim for Pneumocystis prophylaxis: results of 52-week follow-up.
Utsunomiya M, Dobashi H, Odani T, Saito K, Yokogawa N, Nagasaka K, Takenaka K, Soejima M, Sugihara T, Hagiyama H, Hirata S, Matsui K, Nonomura Y, Kondo M, Suzuki F, Nawata Y, Tomita M, Kihara M, Yokoyama-Kokuryo W, Hirano F, Yamazaki H, Sakai R, Nanki T, Koike R, Miyasaka N, Harigai M.
Utsunomiya M, et al. Among authors: suzuki f.
Rheumatol Adv Pract. 2020 Jul 6;4(2):rkaa029. doi: 10.1093/rap/rkaa029. eCollection 2020.
Rheumatol Adv Pract. 2020.
PMID: 33134810
Free PMC article.